Georgios Terzis, Chief Financial Officer at Cosmos Health Inc. (COSM), bought 168,135 shares at $0.25 ($42K) on 2026-06-16, disclosed to the SEC on 2026-06-17.
Cosmos Health CFO Georgios Terzis purchased 168,135 shares at $0.25 on June 16, 2026, marking the largest insider purchase in the company's history. This significant buy from a C-suite executive suggests confidence in the stock's recovery potential following a steep 97% year-to-date decline.
The stock is trading at $0.2434, up 6.61% over the last five days but down 17.27% over the past month. It is currently 23.93% above its 52-week low of $0.1964, indicating the recent pullback has brought the price closer to a key support level.
Catalysts include the company's entry into the animal health market with the C-Scrub brand on June 1, 2026, and the record-breaking insider purchase executed on June 16, 2026. These events provide immediate support and narrative momentum for the stock.
The stock carries extreme volatility risk, evidenced by a beta of 4.117 and a 97.1% year-to-date decline. Furthermore, the recent news from February 15, 2026, notes that insiders who purchased shares faced a 15% tumble, highlighting the potential for sharp price swings despite insider confidence.
Something here stands out, but not much.